Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
14 pending office actions • 11 art units • 10 examiners • 0 of 14 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Kashiv Biosciences LLC is currently dealing with 14 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 10 distinct examiners and 11 distinct art units. The fact that there are 11 art units for 14 actions suggests that the company's research and development span a variety of pharmaceutical classifications.
MCDERMOTT, JEANNIE is the busiest examiner, managing 4 pending office actions. This workload of 4 actions is a portion of the 14 total actions. The remaining actions are shared among the other 10 distinct examiners, indicating that the busiest examiner manages a larger share of the portfolio than the others.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (21%) |
| §102 only | 1 (7%) |
| §112 only | 1 (7%) |
| Double-patenting + other | 2 (14%) |
| Multi-statute (no §101) | 7 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCDERMOTT, JEANNIE | 4 | 59.8% | +15.7% |
| HAQ, SHAFIQUL | 2 | 64.8% | +55.2% |
| REGLAS, GEORGIANA C | 1 | 37.7% | +36.1% |
| WILLIS, DOUGLAS M | 1 | 82.4% | +19.7% |
| CHANDRA, GYAN | 1 | 71.3% | +27.5% |
| ROBINSON, HOPE A | 1 | 67.7% | +43.1% |
| D' AMBROSIO, THEA | 1 | 55.3% | +56.1% |
| COOK, LISA V | 1 | 67.6% | +9.9% |
| CORNET, JEAN P | 1 | 42.1% | +47.5% |
| OSMAN, SOMMER YOUSEF | 1 | 44.7% | +47.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18705711 | INJECTABLE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF BREAST CANCER | WILLIS, DOUGLAS M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19230884 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | MCDERMOTT, JEANNIE | 32d overdue |
| 18262318 | METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE | ROBINSON, HOPE A | 24d overdue |
| 19432904 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | MCDERMOTT, JEANNIE | — |
| 18550920 | NOVEL FORMULATION OF FUSION PROTEIN | CHANDRA, GYAN | — |
| 17922734 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | MCDERMOTT, JEANNIE | — |
| 17919171 | STABLE READY TO DILUTE FORMULATIONS OF CARFILZOMIB | D' AMBROSIO, THEA | — |
| 17627477 | PROCESS FOR SEPARATION AND QUANTITATION OF PROTEINS USING CAPILLARY ELECTROPHORESIS | OSMAN, SOMMER YOUSEF | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19230889 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | MCDERMOTT, JEANNIE | 35d overdue |
| 19230884 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | MCDERMOTT, JEANNIE | 32d overdue |
| 18262318 | METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE | ROBINSON, HOPE A | 24d overdue |
| 18620441 | PROCESS FOR PURIFICATION OF PROTEIN | HAQ, SHAFIQUL | 36d |
| 19432904 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | MCDERMOTT, JEANNIE | — |
| 19432924 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | REGLAS, GEORGIANA C | — |
| 18705711 | INJECTABLE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF BREAST CANCER | WILLIS, DOUGLAS M | — |
| 18620649 | PROCESS FOR PURIFICATION OF PROTEIN | HAQ, SHAFIQUL | — |
| Art Unit | Apps |
|---|---|
| 1777 | 3 |
| 1678 | 2 |
| 1776 | 1 |
| 1651 | 1 |
| 1624 | 1 |
| 1674 | 1 |
| 1652 | 1 |
| 1654 | 1 |
| 1642 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19432904 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | MCDERMOTT, JEANNIE | 1776 | §103§112Other | Non-Final OA | — | Pending | Dec 24, 2025 |
| 19432924 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | REGLAS, GEORGIANA C | 1651 | §102 | Final Rejection | — | Pending | Dec 24, 2025 |
| 19230884 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | MCDERMOTT, JEANNIE | 1777 | §103§112Other | Non-Final OA | 32d overdue | Pending | Jun 06, 2025 |
| 19230889 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | MCDERMOTT, JEANNIE | 1777 | §103Other | Non-Final OA | 35d overdue | Pending | Jun 06, 2025 |
| 18705711 | INJECTABLE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF BREAST CANCER | WILLIS, DOUGLAS M | 1624 | §112DP | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18620441 | PROCESS FOR PURIFICATION OF PROTEIN | HAQ, SHAFIQUL | 1678 | §103Other | Non-Final OA | 36d | Pending | Mar 28, 2024 |
| 18620649 | PROCESS FOR PURIFICATION OF PROTEIN | HAQ, SHAFIQUL | 1678 | §103 | Final Rejection | — | Pending | Mar 28, 2024 |
| 18550920 | NOVEL FORMULATION OF FUSION PROTEIN | CHANDRA, GYAN | 1674 | §103§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18262318 | METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE | ROBINSON, HOPE A | 1652 | §102§103§112 | Final Rejection | 24d overdue | Pending | Jul 20, 2023 |
| 17922734 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | MCDERMOTT, JEANNIE | 1777 | §103§112 | Final Rejection | — | Pending | Nov 01, 2022 |
| 17919171 | STABLE READY TO DILUTE FORMULATIONS OF CARFILZOMIB | D' AMBROSIO, THEA | 1654 | §103§112 | Non-Final OA | — | Pending | Oct 14, 2022 |
| 17934950 | PROCESS FOR PREPARATION OF STABLE PROTEIN SOLUTION | COOK, LISA V | 1642 | §112Other | Non-Final OA | 59d overdue | Pending | Sep 23, 2022 |
| 17779015 | PRODRUGS OF FULVESTRANT | CORNET, JEAN P | 1628 | §103§112DPOther | Non-Final OA | — | Pending | May 23, 2022 |
| 17627477 | PROCESS FOR SEPARATION AND QUANTITATION OF PROTEINS USING CAPILLARY ELECTROPHORESIS | OSMAN, SOMMER YOUSEF | 1794 | §103§112 | Non-Final OA | — | Pending | Jan 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial